SGN-30 (Anti-CD30 monoclonal antibody) is active and well tolerated in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL)

Forero-Torres, A; Bernstein, SH; Gopal, AK; Foss, F; Leonard, JP.; Rosenblatt, JD; Bartlett, NL; Cheson, BD; Epner, E; Hernandez-Illizaliturri, FJ; Proctor, SJ; Brice, P.; Tilly, H.; Haioun, C.; Jerkeman, M; Bosly, André; Lorenz, JM; Barton, J

SGN-30 (Anti-CD30 monoclonal antibody) is active and well tolerated in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL)

Forero-Torres, A

;

Bernstein, SH

;

Gopal, AK

;

Foss, F

;

Barton, J

;et.al.

(2005) 47th Annual Meeting of the American-Society-of-Hematology — Location: Atlanta(Ga) (10.December.2005)

Files

No attached file found for this publication.

Details

Authors

Forero-Torres, A
Author
Bernstein, SH
Author
Gopal, AK
Author
Foss, F
Author
Bosly, AndréUCLouvain
Author
Barton, J
Author

Affiliations

UCLouvainAutre

Citations

APA
Chicago
FWB

Forero-Torres, A., Bernstein, S., Gopal, A., Foss, F., Leonard, JP., Rosenblatt, J., Bartlett, N., Cheson, B., Epner, E., Hernandez-Illizaliturri, F., Proctor, S., Brice, P., Tilly, H., Haioun, C., Jerkeman, M., Bosly, A., Lorenz, J., & Barton, J. (2005). SGN-30 (Anti-CD30 monoclonal antibody) is active and well tolerated in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL). Blood, 106(11), 938A. https://hdl.handle.net/2078.5/140277 (Original work published 2005)